| Streszczenie: | <p><strong>Aim</strong></p>
<p>This paper describes the methods applied to assess the cost-effectiveness of cemented versus uncemented hemiarthroplasty among hip fracture patients in the World Hip Trauma Evaluation Five (WHiTE5) trial.</p>
<p><strong>Methods</strong></p>
<p>A within-trial cost-utility analysis (CUA) will be conducted at four months postinjury from a health system (National Health Service and personal social services) perspective. Resource use pertaining to healthcare utilization (i.e. inpatient care, physiotherapy, social care, and home adaptations), and utility measures (quality-adjusted life years) will be collected at one and four months (primary outcome endpoint) postinjury; only treatment of complications will be captured at 12 months. Sensitivity analysis will be conducted to assess the robustness of the results.</p>
<p><strong>Conclusion</strong></p>
<p>The planned analysis strategy described here records our intent to conduct a within-trial CUA alongside the WHiTE5 trial.</p>
|
|---|